SOPHiA GENETICS S.A. (SOPH) is a Medical healthcare information services company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for SOPHiA GENETICS S.A. in 2026. The next earnings report is expected on November 10, 2026.
Next earnings date
10 Nov 2026
In 83 days
EPS estimate
-0.18
Revenue estimate
23.8M
Past earnings
Latest earnings analysis
SOPHiA GENETICS S.A. missed consensus on EPS in its latest quarter, with EPS of $-0.30 versus an estimate of $-0.21, while revenue beat estimates at $23.31 million, 7.3% above expectations. In the prior quarter EPS also missed expectations while revenue came in ahead of estimates.
No dividend history available.
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
SOPHiA GENETICS S.A. (SOPH) is scheduled to report earnings on November 10, 2026.
SOPHiA GENETICS S.A. (SOPH) last reported earnings on August 4, 2026.
SOPHiA GENETICS S.A. (SOPH) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.